View drug registration information details.
Items | Registration information |
ID | 253 |
No | 253 |
Brand Name | SEMEDX |
Ingredients | SELUMETINIB 25 MG |
Dosage Form | CAPSULE |
Primary Packaging | BOTTLE |
Storage | STORE BELOW 30 C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 60'S/BOTTLE |
Dispensing Category | PRESCRIPTION |
ATC Classification | |
Pharmaceutical Class | ANTINEOPLASTIC |
Indications | TO TREAT NEUROFIBROMATOSIS TYPE 1 (NF1, A NERVOUS SYSTEM DISORDER THAT CAUSES TUMORS TO GROW ON NERVES) IN CHILDREN 2 YEARS OF AGE AND OLDER WHO HAVE PLEXIFORM NEUROFIBROMAS (PN; SOFT TUMORS) THAT CANNOT BE COMPLETELY REMOVED BY SYRGERY. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
No |
Description | WHITE-LIGHT GREEN CAPSULE CONTAINS LIGHT YELLOW CREAM |
Note | |
License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 04 L 1095/24 |
FDD Registration Date | 2024-05-06 |
Expiry Date | 2027-05-05 |
Back to drug list
|